Evaluating the Safety of and Immune Response to HIV-MAG DNA Vaccine With or Without Plasmid IL-12 Adjuvant Delivered Intramuscularly Via Electroporation Followed by VSV-gag HIV Vaccine Boost in Healthy, HIV-Uninfected Adults

NCT01578889 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

100

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

BIOLOGICAL: HIV-MAG vaccine
BIOLOGICAL: IL-12 pDNA adjuvant
BIOLOGICAL: VSV HIV gag vaccine
BIOLOGICAL: Placebo
DEVICE: Ichor Medical Systems TriGrid™ Delivery System (TDS) electroporation (EP) device

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)